Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249077 · ClinicalTrials.gov registry record
Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 8,198
- Enrollment target
NCT03249077: Completed study, sponsored by Kaiser Permanente.
NCT03249077 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 8,198 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03249077 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 8,198 participants
- Enrollment target
Study Summary
In preparation for the roll out of the Medicare Diabetes Prevention Program (DPP) in 2018, Kaiser Permanente Northwest (KPNW), a large, integrated health care system, plans to pilot the implementation of DPP starting in April 2017. Patients 19-75 years old at high risk for diabetes will be offered DPP online or DPP in-person. A pragmatic, rigorous, quantitative and qualitative evaluation will be conducted to compare patients enrolled in DPP (either online or in-person) to those not enrolled to better inform future implementation efforts of DPP within and outside of KPNW. This study is a natural experiment project.
Primary Outcome
Weight obtained from the electronic health record
Interventions
- BEHAVIORAL Digital DPP
- BEHAVIORAL In-person DPP
- OTHER DPP not enrolled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,198 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2021-04-15 |
What the finished NCT03249077 record still lists
NCT03249077 is an observational study that tracks outcomes without assigning an intervention. Its 8,198 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Digital DPP is the first listed.
NCT03249077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03249077 about?
NCT03249077 is a clinical study titled "Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System". In preparation for the roll out of the Medicare Diabetes Prevention Program (DPP) in 2018, Kaiser Permanente Northwest (KPNW), a large, integrated health care system, plans to pilot the implementation of DPP starting in April 2017. Patients 19-75 years old at high risk for diabetes will be offered D...
What is the current status of trial NCT03249077?
This trial is currently completed. The enrollment target is 8,198 participants. The study started on 2017-07-01. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT03249077?
The interventions under investigation include: Digital DPP (BEHAVIORAL), In-person DPP (BEHAVIORAL), DPP not enrolled (OTHER).
Who is sponsoring clinical trial NCT03249077?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT05593484 · 8,060 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI